Free Telemedicine Solution Offered to Healthcare Providers by CompuGroup Medical

Looking for ways to slow the spread of the COVID-19 coronavirus and protect the health of practice staff and the public, medical providers are expressing an increased demand for telemedicine.

CompuGroup Medical reports CGM ELVI Telemedicine allows providers to collect patient information; share images, vitals, and findings; provide care from anywhere at any time; initiate treatments and therapies rapidly; offer continuous care to immobile patients; and reduce the workload of practice staff—all without the risk of spreading infection.

“CGM is one of the leading eHealth companies in the world,” said Benedikt Brueckle, Chief Executive Officer, CompuGroup Medical US. “We are committed to using our position to help the medical community contain the coronavirus, and that’s why we decided to offer a free, six-month subscription to CGM ELVI.”

In its community mitigation guidelines to prevent pandemic influenza, the CDC outlined the importance of flattening the curve, or reducing the number of cases and related demands on hospital and infrastructure while slowing the acceleration of the number of cases.

“The response to this program has been inspiring,” Brueckle said.

Last week, the United States enacted an emergency spending package that includes $500 million to allow Medicare providers to extend telemedicine services to seniors, regardless of where they live.

“It is our hope that the funding from Congress and our offer to provide six months of CGM ELVI electronic video conferencing at no charge will combine to greatly improve the American response to and containment of COVID-19,” Brueckle said.

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”